Fibroblast growth factor 1 ameliorates diabetes-induced splenomegaly via suppressing inflammation and oxidative stress
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 528 (2) , 249-255
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Provincial Natural Science Foundation (LQ18H090011, LQ18H150003, LR18H150001)
- National Natural Science Foundation of China (81801233, 81802251, 81722028)
This publication has 31 references indexed in Scilit:
- Management of Hypertension in Patients with DiabetesCritical Care Nursing Clinics of North America, 2013
- A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and LiverDiabetes, 2012
- Inflammatory links between obesity and metabolic diseaseJournal of Clinical Investigation, 2011
- Minireview: Inflammation and Obesity Pathogenesis: The Hypothalamus Heats UpEndocrinology, 2010
- Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2‐deficient miceGenes to Cells, 2008
- Enhanced Histopathology of the SpleenToxicologic Pathology, 2006
- Structure and function of the spleenNature Reviews Immunology, 2005
- Interleukin-10andRelatedCytokines andReceptorsAnnual Review of Immunology, 2004
- Inflammation and Insulin ResistanceDiabetes Care, 2003
- Splenomegaly, hypersplenism and coagulation abnormalities in liver diseaseBest Practice & Research Clinical Gastroenterology, 2000